Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00794
|
|||||
Drug Name |
Cisapride
|
|||||
Synonyms |
Acenalin; (+-)-Cisapride; 104860-73-3; 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide; 4-amino-5-chloro-N-[1-{3-[(4-fluorophenyl)oxy]propyl}-3-(methyloxy)piperidin-4-yl]-2-(methyloxy)benzamide; 4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide; 81098-60-4; Acenalin; Acpulsif; Alimix; Alimix Forte; Alipride; Cipride; Cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-o-anisamide; Cisaprida; Cisaprida [INN-Spanish]; Cisaprida [Spanish]; Cisapride (USAN/INN); Cisapride [USAN:BAN:INN:JAN]; Cisapridum; Cisapridum [INN-Latin]; Cisapridum [Latin]; Cisapron; Cisawal; Colinorm; DCSUBABJRXZOMT-UHFFFAOYSA-N; DSSTox_CID_2825; Dispep; E-1454; Enteropride; Esorid; Guptro; Kaudalit; Kinestase; Prepulsid; Prepulsid (TN); Presid; Pridesia; Propulsid; Propulsid (TN); Propulsid Quicksolv; Propulsin; Pulsid; R 51619; R-51619; Rapulid; Risamal; Risamol; Syspride; T 1341; Unamol; Unipride; Vomiprid; Vomipride; cisapride
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Gastrointestinal Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C23H29ClFN3O4
|
|||||
Canonical SMILES |
COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
|
|||||
InChI |
InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)
|
|||||
InChIKey |
DCSUBABJRXZOMT-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 81098-60-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 465.9 | Topological Polar Surface Area | 86 | ||
Heavy Atom Count | 32 | Rotatable Bond Count | 9 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
XLogP |
3.4
|
|||||
PubChem CID | ||||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.